State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.
Listing ID:
29345918591
Licence(s) Held:
Previously licences for Cultivation, Processing, and Medical Sales are in the final stages for reinstatement. The facilities were designed to meet EU-GACP and EU-GMP standards
Purchase or investment out of CCAA free and clear of all historical liabilities, encumbrances, and unsecured claims—a “clean slate” opportunity. The vendor is also seeking a $2 million in restructuring financing.
Listing Details:
A wholly owned, 3-building campus totaling ~130,000 sq. ft. situated on 37.21 acres of industrial land in Alberta.
Includes 80,342 sq. ft. of dedicated cultivation space capable of producing ~20.5 tonnes (20,500 KG/yr) of dried flower annually
Features an EU-GMP designed hub with advanced drying, precision curing, and integrated extraction labs to maximize margins
Equipped with automated fertigation, multi-zonal HVAC, precision lighting, and modular benching systems.
Includes a dedicated 6,600 sq. ft. space for elite breeding and mother-stock management, offering a turnkey platform for cultivating a premium genetics portfolio.
High-intensity medical production optimized for low-cost, high-yield output with no third-party leasehold risks.
This opportunity is structured as a strategic investment or 100% acquisition, allowing for a debt-free transition of the business and its core assets. Designed to provide a "clean slate" ownership, stripped of historical liabilities and unsecured claims.
Vendor is also seeking $2 million in restructuring financing.
Restructuring Financing Deadline: Binding offers/term sheets must be submitted by January 21, 2026.
Acquisition Deadline: Non-binding expressions of interest are required by January 31, 2026.
29345918591
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.
45967461758
Leading online patient acquisition & retention platform: 20,000+ active patient ecosystem and full Canadian regulatory compliance
Purpose-built for high-efficiency patient acquisition and retention within the Canadian medical cannabis sector, this low-overhead, tech-enabled platform provides a high-margin gateway for LPs and healthcare practitioners seeking to scale their patient bases quickly. Designed with scalability in mind, the platform is poised to expand into adjacent care segments and international markets
